Literature DB >> 23442503

Two-year outcomes after vaginal prolapse reconstruction with mesh pelvic floor repair system.

Marianna Alperin1, Rennique Ellison, Leslie Meyn, Elizabeth Frankman, Halina M Zyczynski.   

Abstract

OBJECTIVE: The aim of this study was to assess anatomical and functional outcomes 2 years after prolapse repair using vaginal mesh repair system.
METHODS: Women enrolled in a 12-month observational study of outcomes after transvaginal mesh-augmented prolapse repair were invited to participate in an extended follow-up. Subjects completed questionnaires assessing pelvic symptoms, quality of life, global satisfaction, and a pelvic examination for anatomical support and mesh complications.
RESULTS: Of 118 eligible women, 85 enrolled, 82 provided subjective data at 24 months, and pelvic examination/Pelvic Organ Prolapse Quantification data are available from 79 women. Total, anterior, and posterior Prolift kits were used in 47 (55%), 25 (29%), and 13 (15%), respectively. At baseline, most of the women had stage III prolapse (75%), with the anterior compartment constituting the leading edge in 71% of subjects. At 24 months, Pelvic Organ Prolapse Quantification measures were significantly improved from baseline in all compartments, with 51 (65%) stage 0/I, 25 (31%) stage II, 3 (4%) and stage III (P < 0.001), as were quality of life scores (P < 0.001), with the exception of sexual function. Symptomatic prolapse was reported by 7 (8.5%) women, of which 4 demonstrated prolapse in the nonoperated compartment. Three subjects (4%) reported persistent pelvic pain. The 2-year mesh exposure incidence was at least 13% (11/85). The proportion reporting dyspareunia was 28.9% (13/45) and was unchanged from baseline. The median global satisfaction was 9.3 (range 2.0-10.0).
CONCLUSIONS: Anatomical support, symptom relief, and satisfaction are high 24 months after mesh-augmented vaginal prolapse repair, although mesh exposure and new onset prolapse of the nonoperated compartment are not uncommon.

Entities:  

Mesh:

Year:  2013        PMID: 23442503      PMCID: PMC4261688          DOI: 10.1097/SPV.0b013e3182841d4b

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  25 in total

1.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

2.  Pelvic organ descent and symptoms of pelvic floor disorders.

Authors:  Chiara Ghetti; W Thomas Gregory; S Renee Edwards; Lesley N Otto; Amanda L Clark
Journal:  Am J Obstet Gynecol       Date:  2005-07       Impact factor: 8.661

3.  Sexual function before and after sacrocolpopexy for pelvic organ prolapse.

Authors:  Victoria L Handa; Halina M Zyczynski; Linda Brubaker; Ingrid Nygaard; Nancy K Janz; Holly E Richter; Patricia A Wren; Morton B Brown; Anne M Weber
Journal:  Am J Obstet Gynecol       Date:  2007-12       Impact factor: 8.661

4.  Vaginal wall descensus and pelvic floor symptoms in older women.

Authors:  Catherine S Bradley; Ingrid E Nygaard
Journal:  Obstet Gynecol       Date:  2005-10       Impact factor: 7.661

5.  Vaginal versus abdominal reconstructive surgery for the treatment of pelvic support defects: a prospective randomized study with long-term outcome evaluation.

Authors:  J T Benson; V Lucente; E McClellan
Journal:  Am J Obstet Gynecol       Date:  1996-12       Impact factor: 8.661

6.  Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects.

Authors:  Steven Swift; Patrick Woodman; Amy O'Boyle; Margie Kahn; Michael Valley; Deirdre Bland; Wei Wang; Joe Schaffer
Journal:  Am J Obstet Gynecol       Date:  2005-03       Impact factor: 8.661

7.  Tension-free polypropylene mesh for vaginal repair of anterior vaginal wall prolapse.

Authors:  Renaud de Tayrac; Amélie Gervaise; Aurélia Chauveaud; Hervé Fernandez
Journal:  J Reprod Med       Date:  2005-02       Impact factor: 0.142

8.  The role of apical vaginal support in the appearance of anterior and posterior vaginal prolapse.

Authors:  Jerry L Lowder; Amy J Park; Rennique Ellison; Chiara Ghetti; Pamela Moalli; Halina Zyczynski; Anne M Weber
Journal:  Obstet Gynecol       Date:  2008-01       Impact factor: 7.661

Review 9.  Abdominal sacrocolpopexy: a comprehensive review.

Authors:  Ingrid E Nygaard; Rebecca McCreery; Linda Brubaker; AnnaMarie Connolly; Geoff Cundiff; Anne M Weber; Halina Zyczynski
Journal:  Obstet Gynecol       Date:  2004-10       Impact factor: 7.661

Review 10.  The menopause and sexual functioning: a review of the population-based studies.

Authors:  Lorraine Dennerstein; Jeanne L Alexander; Krista Kotz
Journal:  Annu Rev Sex Res       Date:  2003
View more
  4 in total

1.  Vaginal native tissue repair versus transvaginal mesh repair for apical prolapse: how utilizing different methods of analysis affects the estimated trade-off between reoperation for mesh exposure/erosion and reoperation for recurrent prolapse.

Authors:  Alexis A Dieter; Marcella G Willis-Gray; Alison C Weidner; Anthony G Visco; Evan R Myers
Journal:  Int Urogynecol J       Date:  2015-02-03       Impact factor: 2.894

2.  Subjective and Objective Evaluation of Total Pelvic Floor Reconstruction with Six-Arm Mesh in Patients with Severe Pelvic Organ Prolapse: A 1-Year Retrospective Study.

Authors:  Ying Zhao; Zhi-Jun Xia; Qing Hu; Mei-Ying Qin
Journal:  Ther Clin Risk Manag       Date:  2020-09-14       Impact factor: 2.423

3.  Analysis of changes in sexual function in women undergoing pelvic organ prolapse repair with abdominal or vaginal approaches.

Authors:  Priyanka Gupta; James Payne; Kim A Killinger; Michael Ehlert; Jamie Bartley; Jason Gilleran; Judy A Boura; Larry T Sirls
Journal:  Int Urogynecol J       Date:  2016-06-24       Impact factor: 2.894

4.  Pain Scores and Exposure Rates after Polypropylene Mesh for Pelvic Organ Prolapse.

Authors:  Jana D Illston; Jeffrey B Garris; Holly E Richter; Thomas L Wheeler
Journal:  South Med J       Date:  2015-12       Impact factor: 0.954

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.